A GRANDE VARIAÇÃO NOS TIPOS DE SINTOMAS E AS DOENÇAS SECUNDÁRIAS CAUSADAS PELA COVID-19

Autores

  • LUIS CARLOS OLIVEIRA GONCALVES Doutorando em Ciências da Saúde - UFMT
  • Marcio Vinicius de Abreu Verli PPG em Ciências da Saúde-Universidade Federal de Mato Grosso (UFMT), Brasil;
  • Ana Emília Braga Queiroz Graduação em Enfermagem do Centro Universitário do Rio de Janeiro (UNIRJ), Brasil
  • Aline Miguel Caetano Graduação em Enfermagem do Centro Universitário do Rio de Janeiro (UNIRJ), Brasil.
  • Ivana Oliveira dos Santos Gama Graduação em Enfermagem do Centro Universitário do Rio de Janeiro (UNIRJ), Brasil
  • Rafaela Gomes Freitas Graduação em Enfermagem do Centro Universitário do Rio de Janeiro (UNIRJ), Brasil
  • Eva de Fátima Rodrigues Paulino Graduação em Enfermagem do Centro Universitário do Rio de Janeiro (UNIRJ), Brasil
  • Aníbal Monteiro de Magalhães Neto PPG em Imunologia e Parasitologia Básicas e Aplicadas–Universidade Federal de Mato Grosso (UFMT), Brasil;

DOI:

https://doi.org/10.33053/biomotriz.v15i1.487

Palavras-chave:

SARS-CoV-2. Pandemia. Coronavírus.

Resumo

Em dezembro de 2019 surgiu o primeiro caso de COVID-19 na China e rapidamente atingiu todos os continentes. A grande quantidade de questões e dúvidas a serem respondidas trouxe um desafio para pesquisadores de todo o mundo. A presente revisão narrativa da literatura teve como objetivo identificar os principais sintomas da COVID-19 e as doenças causadas secundariamente. A COVID-19, doença causada pelo SARS-CoV-2, tem apresentado uma grande variabilidade de sinais e sintomas, tropismos a diferentes órgãos e sistemas, tem gerado doenças crônicas secundárias a importantes sistemas como o respiratório, cardiovascular, nervoso, renal, hepático e até mesmo ocular. Além dos fatores supracitados, a saúde mental da população e dos profissionais de saúde tem sido afetada pelo excesso de informações desencontradas pela imprensa e pelas mídias sociais. Já o público formado por crianças e adolescentes tem tido como principal agente agressor da saúde mental o isolamento social. Apesar de mais de um ano passado do início da pandemia, muito pouco ainda se sabe sobre o comportamento deste vírus em diferentes populações, sexos, faixas etárias e quais problemas secundários esta doença pode deixar a seus infectados.

Referências

ABBOUD, H. et al. COVID-19 and SARS-CoV- 2 infection: Pathophysiology and clinical effects on the nervous system. World Neurosurg, v. 140, p. 49-53, 2020.

AHMED, M. Z. et al. Epidemic of COVID-19 in China and Associated Psychological Problems. Asian Journal Psychiatry, v. 51, p. 10209, 2020.

ALSAIED, T. et al. Review of Cardiac Involvement in Multisystem Inflammatory Syndrome in Children. Circulation, v. 143, n. 1, p. 78-88, 2021.

BANERJEE, D. The COVID-19 outbreak: Crucial role the psychiatrists can play. Asian Journal Psychiatry, v. 50, p. 102014, 2020.

BERGER, J. R. COVID-19 and the nervous system. Journal Neurovirology, v. 26, n. 2, p. 143-148, 2020.

BIADSEE, A. et al. Olfactory and oral manifestations of COVID-19: sex-related symptoms - A potential pathway to early diagnosis. Otolaryngology-Head and Neck Surgery, v. 163, n. 4, p. 722-728, 2020.

BROOKS, S. K. et al. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet Infect Disease, v. 395, n. 10227, p. 912–920, 2020.

CHEN, T. et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ [Internet], v. 368, n. 1091, p. 10.1136/bmj.m1091, 2020.

CONSIGLIO, C. R. et al. The immunology of multisystem inflammatory syndrome in children with COVID-19. Cell, v. 183, n. 4, p. 968-981, 2020.

CRODA, J. et al. COVID-19 in Brazil: advantages of a socialized unified health system and preparation to contain cases. Revista da Sociedade Brasileira de Medicina Tropical [Internet], v. 1, n. 53, p. e20200167, 2020.

DENG, J. et al. The prevalence of depression, anxiety, and sleep disturbances in COVID-19 patients: a meta-analysis. Annals of the New York Academy of Science, v. 1486, n. 1, p. 90-111, 2021.

DUARTE, M. Q. et al. COVID-19 e os Impactos na Saúde Mental, uma amostra do Rio Grande do Sul, Brasil. Ciência e Saúde Coletiva, v. 25, n. 9, p. 3401-3411, 2020.

EVANS, C.; DAVIES, P. SARS-CoV-2 paediatric inflammatory syndrome. Paediatric Children and Health (Oxford), v. 31, n. 3, p. 110-115, 2021.

GALEOTI, C.; BAYRY, J. Autoimmune and inflammatory diseases following COVID-19. Nature Reviews Rheumatologyc, v. 16, n. 8, p. 413-414, 2020.

GAO, J. et al. Mental health problems and social media exposure during COVID-19 outbreak. PLoS One, v. 15, n. 4, p. 1-10, 2020.

GARRIDO, R. G.; GARRIDO, F. S. R. G. COVID-19: Um panorama com ênfase em medidas restritivas de contato interpessoal. Interfaces Científicas - Saúde e Ambiente, v. 8, n. 2, p. 127–141, 2020.

GONÇALVES, L. C. O.; NETO, A. M. M. O uso de agentes terapêuticos já existentes para o enfrentamento à COVID-19. South American Journal of Basic Education, Technical and Technological, v. 7, n. 2, p. 912-921, 2020.

GREENE, A. G. et al. Toxic Shock-like syndrome and COVID-19: multisystem Inflammatory syndrome in children (MIS-C). The American Journal of Emergency Medicine, v. 38, n. 11, p. e5-2492, 2020.

HALDRUP, M.; JOHANSEN, M. I.; FJAELDSTAD, A. W. Anosmia and ageusia as primary symptoms of COVID-19. Ugeskrifty for Laeger, v. 182, n. 18, p. 04200205, 2020.

HAN, C. et al. Digestive symptoms in COVID-19 patientes with mild disease severity: clinical presentation, stool viral RNA testing, and outcomes. American Journal of Gastroenterology, v. 115, n. 6, p. 916-923, 2020.

HERTZ, M.; BARRIOS, L. C. Adolescent mental health, COVID-19, and the value of school-community partnerships. Injury Prevention, v. 27, n. 1, p. 85-86, 2021.

HESARI, F. S.; HOSSEINZADEH, S. S.; SARDROUD, M. A. A. M. Review of COVID-19 and male genital tract. Andrologia. v. 53, n. 1, p. e13914, 2021.

HOLMES, E. A. et al. Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science. Lancet Psychiatry, v. 7, n. 6, p. 547-560, 2020.

HONG, N. et al. Evaluation of ocular symptoms and tropism of SARS-CoV-2 in patients with COVID-19. Acta Ophthalmology, online ahead of print, DOI 10.1111/aos.14445, 2020.

ISER, B. P. M. et al. Suspected COVID-19 case definition: a narrative review of the most frequent signs and symptoms among confirmed cases. Epidemiologia e Serviços de Saúde, v. 29, n. 3, p. e202023, 2020.

JIANG, L. et al. COVID-19 and multisystem inflammatory syndrome in children and adolescents. Lancet Infect Disease, v. 20, n. 11, p. 276-288, 2020.

JIN, X. et al. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut, v. 69, n. 6, p. 1002-1009, 2020.

JOTHIMANI, D. et al. COVID-19 and the liver. Journal of Hepatology, v. 73, n. 5, p. 1231-1240, 2020.

KABEERDOSS, J. et al. Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestions and management. Rheumatology International, v. 21, p. 1-14, 2021.

MORRIS, S. B. et al. Case Series of Multisystem Inflammatory Syndrome in Adults Associated with SARS-CoV-2 Infection - United Kingdom and United States, March-August 2020. Morbidity and Mortality Weekly Report, v. 69, n. 40, p. 1450-1456, 2020.

ORNELL, F. et al. “Pandemic fear” and COVID-19: mental health burden and strategies. Brazilian Journal of Psychiatry, v. 42, n. 3, p. 232-235, 2020.

PALMEIRA, P. P. et al. Why is SARS-CoV-2 infection milder among children? Clinics, v. 75, p. e1947, 2020.

MAHASE E. Covid-19: concerns grow over inflammatory syndrome emerging in children. BMJ, v. 369, p. m1710, 2020.

PAN, L. et al. Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study. American Journal of Gastroenterology [Internet], v. 115, n. 5, p. 766- 73, 2020.

PRADO, A. D. et al. A saúde mental dos profissionais de saúde frente à pandemia do COVID-19: uma revisão integrativa. Revista Eletrônica Acervo Saúde, v. 46, p. e4128, 2020.

PUELLES, V. C. et al. Multiorgan and renal tropism of SARS-CoV-2. New England Jornal Medidice, v. 383, n. 6, p. 590-592, 2020.

RIPHAGEN, S. et al. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet, v. 395, n. 10237, p. 1607-1608, 2020.

SACHDEVA, M. et al. Cutaneous manifestions of COVID-19: report of three cases and a review of literature. Journal of Dermatology and Science, v. 98, n. 2, p. 75-81, 2020.

SCHETT, G.; STICHERLING, M.; NEURATH, M. F. COVID-19: risk for cytokine targeting in chronic inflammatory diseases. Nature Reviews Immunology, v. 20, n. 5, p. 271-272, 2020.

SHIGEMURA, J. et al. Public responses to the novel 2019 coronavirus 2019 nCoV in Japan: Mental health consequences and target populations. Psychiatry and Clinical Neurosciences, v. 74, n. 4, p. 281–282, 2020.

SILVA, C. A. et al. Spotlight for healthy and preexisting chronic diseases adolescents during COVID 19 pandemic. Clinics, v. 75, p. e1931, 2020.

SINGH, S. et al. Impact of COVID-19 and lockdown on mental health of children and adolescents: a narrative review with recommendations. Psychiatry Research, v. 293, p. 1-11, 2020.

STELNICKI, A. M.; CARLETON, R. N.; REICHERT, C. Nurses mental health and well-being: COVID-19 impacts. Canadian Journal of Nursing Research, v. 52, n. 3, p. 237-239, 2020.

STRUYF, T. et al. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease. Cochrane Database System Review, v. 7, n. 7, p. 1-96, 2020.

SHUJA, K. et al. COVID-19 pandemic and impeding global mental health implications. Psychiatria Danubina, v. 32, n. 1, p. 32-35, 2020.

TANNER, T,; WAHEZI, D. M. Hyperinflammation and the utility of the immunomodulatory medications in children with COVID-19. Paediatrics Respiritary Review, v. 35, p. 81-87, 2020.

VINDEGAARD, N.; BENROS, M. E. COVID-19 pandemic and mental health consequences: systematic review of the current evidence. Brain Behavioral Immunology, v. 89, p. 531-542, 2020.

WALTON, M.; MURRAY, E.; CHRISTIAN, M. D. Mental health care for medical staff and affiliated healthcare workers during the COVID-19 pandemic. European Heart Journal: Acute Cardiovascular Care, v. 9, n. 3, p. 241-247, 2020.

WANG, C. et al. Immediate psychological responses and associated factors during the initial stage of the 2019 coronavirus disease (covid-19) epidemic among the general population in China. International Journal of Environmental Research and Public Health, v. 17, n. 5, p. e1729, 2020.

WILSON, J. M.; LEE, J.; SHOOK, N. J. COVID-19 worries and mental health: the moderating effect of age. Aging Mental Health, v. 25, n. 7, p. 1289-1296, 2021.

WOSTYN, P. COVID-19 and chronic fatigue syndrome: Is the worst yet to come? Medicine Hypoteses, V. 146, p. 110469, 2021.

WU, C. I. et al. SARS-CoV-2, COVID-19, and inherited arrhythmia syndromes. Hearth Rhythm, v. 17, n. 9, p. 1456-1462, 2020.

WU, Z.; MCGOOGAN, J. M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in china: summary HP a report of 72 314 cases from the chinese center for disease control and prevention. JAMA [Internet], v. 323, n. 13, p. 1239-42, 2020.

XIAU, Y. et al. Impacts of Working From Home During COVID-19 Pandemic on Physical and Mental Well-Being of Office Workstation Users. Journal of Occupational and Environmental Medicine, v. 63, n. 3, p. 181-190, 2021.

ZHU, N. et al. Anovel coronavirus from patients with pneumonia in China, 2019. New England Journal of Medicine [Internet], v. 382, n. 8, p. 727-33, 2020.

Downloads

Publicado

2021-08-23

Como Citar

OLIVEIRA GONCALVES, L. C., de Abreu Verli, M. V., Braga Queiroz, A. E., Miguel Caetano, A., Oliveira dos Santos Gama, I., Gomes Freitas, R., Rodrigues Paulino, E. de F., & Monteiro de Magalhães Neto, A. (2021). A GRANDE VARIAÇÃO NOS TIPOS DE SINTOMAS E AS DOENÇAS SECUNDÁRIAS CAUSADAS PELA COVID-19. BIOMOTRIZ, 15(1), 259-268. https://doi.org/10.33053/biomotriz.v15i1.487

Edição

Seção

Artigos